Progress in clinical application of autologous ozonized blood transfusion
Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 2
Abstract
Autologous ozonized blood transfusion (AOBT) is a therapeutic method that mixes blood with medical ozone in vitro and then reinfuses it into the body. It has been widely used in the auxiliary treatment of ischemia, hypoxia, autoimmune diseases and cancer. The mechanism of ozone therapy is still unclear, and no unified standard for the concentration, frequency and course of AOBT treatment has been established. This article aims to review the mechanism and clinical application of AOBT.
Authors and Affiliations
Xiaoqiong LONG, Jianjun WU, Shuming ZHAO
Keywords
Related Articles
- EP ID EP738478
- DOI 10.13303/j.cjbt.issn.1004-549x.2023.02.004
- Views 7
- Downloads 0
Recruitment strategies of blood donors during the COVID-19 epidemic
Objective To explore the recruitment strategy of blood donors under the situation of blood supply shortage during the COVID-19 epidemic. Methods The theory of planned behavior and the stage change model of behavior were...
Expert consensus on intraarticular injection of autologous apheresis platelet-rich plasma in the treatment of knee osteoarthritis
Knee osteoarthritis (KOA) is one of the most common musculoskeletal diseases. Platelet-rich plasma (PRP) has been widely used in the treatment of KOA. However, the effectiveness of KOA treatment has been affected due to...
Distribution and transfusion efficacy of unexpected antibody
Objective To investigate the clinical characteristics and antibody distribution as well as evaluate the transfusion efficacy in unexpected antibody positive patients. Methods A total of 12 235 patients from January 1, 20...
Perioperative allogenic blood transfusion for single disease in patients undergoing spinal deformity correction surgery:a longitudinal observational study
Objective To analyze the profile of perioperative allogenic blood transfusion for single disease in patients who underwent spinal deformity correction surgery and risk factors of the blood transfusion, in order to provid...
Research progress of SMIM1 in Vel blood type, tumor and plasmodium infection
Small integral membrane protein 1(SMIM1) gene encodes Vel blood group antigen, and homozygous deletion of 17 bases pairs in its exon 3 leads to Vel negative phenotype. As a rare phenotype, accurate identification and pre...